How Your Body Activates Peptide Hormones: The Enzymes PC1 and PC2 Explained
Prohormone convertases PC1 and PC2 are the essential enzymes that cut inactive peptide precursors into their active forms, and they follow distinctly different activation pathways within the cell.
Quick Facts
What This Study Found
PC1 and PC2 follow markedly different activation pathways. PC1 undergoes rapid propeptide cleavage in the endoplasmic reticulum and is further activated by a carboxyl-terminal processing event. PC2, by contrast, has much longer folding times, exits the ER without propeptide cleavage, and requires association with the neuroendocrine-specific protein 7B2 to become catalytically active.
The 7B2 protein is internally cleaved into a 21-kDa fragment and a 31-residue carboxy-terminal peptide once the complex reaches the trans-Golgi network. PC2 propeptide removal occurs later in secretory granules, likely through autocatalysis, but without prior 7B2 encounter, PC2 cannot generate an active enzyme. A 36-residue internal segment of 7B2 appears to mediate the critical conformational changes.
Key Numbers
PC1: rapid ER propeptide cleavage + C-terminal activation; PC2: slow folding, requires 7B2, propeptide removal in secretory granules; 7B2 cleaved into 21-kDa + 31-residue fragments
How They Did This
Narrative review of published cell biology, biochemistry, and molecular biology research on PC1 and PC2 prohormone convertases in neuroendocrine cells.
Why This Research Matters
PC1 and PC2 are the master switches for peptide hormone activation. They process proinsulin into insulin, POMC into endorphins and ACTH, and hundreds of other prohormones into their active forms. Mutations or dysfunction in these enzymes cause severe hormonal disorders including obesity, diabetes, and adrenal insufficiency. Understanding their biology is essential for both basic peptide science and developing therapies that target the peptide processing machinery.
The Bigger Picture
This review provides foundational knowledge for the entire peptide therapeutics field. Every time a cell produces insulin, growth hormone, endorphins, or any other peptide hormone, PC1 and PC2 are doing the processing work. Understanding these enzymes informs drug development for diabetes, obesity, pain, and neuroendocrine tumors — and helps explain why some genetic mutations cause devastating hormonal diseases.
What This Study Doesn't Tell Us
Review from 1999; some mechanisms described as unknown have since been clarified. Does not cover subsequently identified prohormone convertases or regulatory pathways.
Questions This Raises
- ?Can targeting PC1 or PC2 activity be used to modulate peptide hormone levels for therapeutic purposes?
- ?What happens in diseases where PC1 or PC2 are mutated, and can these defects be corrected?
- ?Could the 7B2 protein's role in PC2 activation be exploited to selectively regulate specific peptide hormone processing?
Trust & Context
- Key Stat:
- 2 master enzymes for peptide activation PC1 and PC2 are responsible for processing virtually all neuroendocrine peptide precursors into their biologically active forms
- Evidence Grade:
- This is a comprehensive narrative review synthesizing the state of knowledge about PC1 and PC2 cell biology as of 1999. It's a reference-grade summary of established biochemistry rather than a primary research study with novel findings.
- Study Age:
- Published in 1999, this is a foundational review that remains relevant for understanding core PC1/PC2 biology. While specific molecular details have been updated by subsequent research, the fundamental cell biology described here is still accurate and widely cited.
- Original Title:
- The cell biology of the prohormone convertases PC1 and PC2.
- Published In:
- Progress in nucleic acid research and molecular biology, 63, 69-108 (1999)
- Authors:
- Muller, L, Lindberg, I
- Database ID:
- RPEP-00543
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What do prohormone convertases actually do?
They are molecular scissors inside your cells that cut large, inactive precursor proteins into smaller, active peptide hormones. For example, PC1 and PC2 together process proinsulin into active insulin, and POMC into endorphins and ACTH. Without these enzymes, your body couldn't make functional versions of hundreds of peptide hormones.
What happens if PC1 or PC2 don't work properly?
Mutations in PC1 cause a rare condition involving severe childhood obesity, hormonal deficiencies, and intestinal problems because multiple peptide hormones can't be properly processed. PC2 deficiency primarily affects processing of certain neuropeptides. These rare genetic conditions highlight how critical these enzymes are for normal hormone production.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00543APA
Muller, L; Lindberg, I. (1999). The cell biology of the prohormone convertases PC1 and PC2.. Progress in nucleic acid research and molecular biology, 63, 69-108.
MLA
Muller, L, et al. "The cell biology of the prohormone convertases PC1 and PC2.." Progress in nucleic acid research and molecular biology, 1999.
RethinkPeptides
RethinkPeptides Research Database. "The cell biology of the prohormone convertases PC1 and PC2." RPEP-00543. Retrieved from https://rethinkpeptides.com/research/muller-1999-the-cell-biology-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.